Abstract

Anatomic segmentectomy was first described in 1939 for the treatment of benign lung conditions (1). The usual indications also include metastatic disease to the lung when ta parenchyma-sparing procedure is anticipated Nevertheless, anatomic pulmonary segmentectomy has been demonstrated to be effective in the resection of small primary lung cancers (2,3). Recently there has been a renewed interest in the use of anatomic segmentectomy, especially for patients unable to tolerate lobectomy because of poor cardiopulmonary function or severe comorbidities. Several recently published studies have shown that segmentectomy can be performed safely without compromising oncologic results (3-6).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call